Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 3;48(1):E11-E12.
doi: 10.1503/jpn.220154. Print 2023 Jan-Feb.

Utilizing pharmacogenetics when treating first episode psychosis

Theo Korchia  1 , Ridha Joober  1 , Raphaelle Richieri  1 , Priyadharshini Sabesan  1 , Lena Palaniyappan  1
Affiliations

Utilizing pharmacogenetics when treating first episode psychosis

Theo Korchia et al. J Psychiatry Neurosci. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: R. Joober served as speaker and member of advisory board committees for Pfizer, Janssen, BMS, Sunovian, Myelin, Otsuka, Lundbeck, shire and Perdue. He also received grants from Janssen, BMS, Otsuka, Lundbeck, Astra Zeneca and HLS. P. Sabesan has received speaker fees from Lundbeck Canada. L. Palaniyappan is co-editor in chief of the Journal of Psychiatry and Neuroscience but was not involved in the review of or decision to accept the manuscript for publication. He has received personal fees from Janssen Canada, Otsuka Canada, SPMM Course Limited UK, and the Canadian Psychiatric Association; book royalties from Oxford University Press; and investigator- initiated educational grants from Sunovion, Janssen Canada, and Otsuka Canada. All of these are unrelated to the present work. No other competing interests were declared.

Comment in

References

    1. Murray M. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents. J Pharm Pharmacol 2006;58:871–85. - PubMed
    1. Bousman CA, Bengesser SA, Aitchison KJ, et al. . Review and consensus on pharmacogenomic testing in psychiatry. Pharmacopsychiatry 2021;54:5–17. - PubMed
    1. Del Tredici AL, Malhotra A, Dedek M, et al. . Frequency of CYP2D6 alleles including structural variants in the United States. Front Pharmacol 2018;9:305. - PMC - PubMed
    1. Gaedigk A, Sangkuhl K, Whirl-Carrillo M, et al. . Prediction of CYP2D6 phenotype from genotype across world populations. Genet Med 2017;19:69–76. - PMC - PubMed
    1. Maruf AA, Fan M, Arnold PD, et al. . Pharmacogenetic testing options relevant to psychiatry in Canada: options de tests pharmacogénétiques pertinents en psychiatrie au Canada. Can J Psychiatry 2020;65:521–30. - PMC - PubMed

Publication types